These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8146768)

  • 1. [Genealogy and the clinical manifestations of familial hyperlipidemias types IIa and IIb].
    Lipovetskiĭ BM
    Ter Arkh; 1993; 65(12):34-8. PubMed ID: 8146768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinico-genetic aspects of familial hypercholesterolemia and their applied significance].
    Lipovetskiĭ BM; Mandel'shtam MIu; Gaĭtskhoki VS; Vasil'eva LE
    Ter Arkh; 1996; 68(1):24-9. PubMed ID: 8644024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
    Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for early detection and treatment of hyperlipidemias.
    Stein EA
    Prog Clin Biol Res; 1985; 188():61-6. PubMed ID: 4059259
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and biochemical features of atherosclerosis main risk factors in children of probands with primary hyperlipidemia].
    Alidzhanova KhG; Tvorogova MG; Rozhkova TA; Balakhonova TV; Vorob'eva LP; Masenko VP; Kukharchuk VV
    Ter Arkh; 1998; 70(1):19-23. PubMed ID: 9532645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of hyperlipidemia in high school student--Part 1].
    Ebina H; Funato T; Kawamura T; Ishimori A; Satoh K; Terasaki S; Chiba M; Yanagiya T
    Rinsho Byori; 1993 Sep; 41(9):1049-53. PubMed ID: 8254968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
    J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary hyperlipoproteinemias--pathophysiology, clinical aspects and genetics].
    Keller C; Zöllner N
    Internist (Berl); 1992 Jan; 33(1):9-15. PubMed ID: 1551767
    [No Abstract]   [Full Text] [Related]  

  • 9. Recognition of familial dyslipidemias in 5-year-old children using the lipid phenotypes of parents. The STRIP project.
    Lapinleimu J; Nuotio IO; Lapinleimu H; Simell OG; Rask-Nissila L; Viikari JS
    Atherosclerosis; 2002 Feb; 160(2):417-23. PubMed ID: 11849666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal arcus in Japanese family with type IIa hyperlipoproteinemia.
    Hayasaka S; Honda M; Kitaoka M; Chiba R
    Jpn J Ophthalmol; 1984; 28(3):254-8. PubMed ID: 6527440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory-based assessment of plasma lipids and lipoproteins for the classification of familial hypercholesterolemic and hypertriglyceridemic states.
    Demacker PN
    Semin Vasc Med; 2004 Feb; 4(1):13-22. PubMed ID: 15199429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and treatment of familial hypercholesterolemia in children and adolescents].
    Ose L; Tonstad S; Vesterhus P; Wefring KW
    Tidsskr Nor Laegeforen; 1995 Nov; 115(28):3499-503. PubMed ID: 7491603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Familial disorders of lipid metabolism in childhood].
    Herrmann W; Biermann J
    Z Arztl Fortbild (Jena); 1986; 80(17):725-8. PubMed ID: 3811401
    [No Abstract]   [Full Text] [Related]  

  • 15. [Premature atherosclerosis in a 17-year-old male with diabetes mellitus and familial dyslipoproteinemia].
    Diaz Moncada SF; Quintanilla J; Lerman I; García Rubí E; Verdejo J; Posadas C
    Arch Inst Cardiol Mex; 1992; 62(3):257-62. PubMed ID: 1632717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for familial hypercholesterolemia: what is the most effective strategy?
    Daniels SR
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):130-1. PubMed ID: 18059381
    [No Abstract]   [Full Text] [Related]  

  • 17. [Familial hypercholesterolemia: do we know how to diagnose it correctly?].
    Soska V
    Vnitr Lek; 2000 Jan; 46(1):19-23. PubMed ID: 10953659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apolipoprotein E and activity of cholesterol esters transport in type IIA and IIB hyperlipoproteinemia].
    Tvorogova MG; Rozhkova TA; Semenova OA; Lupanov VP; Nuraliev EIu ; Kukharchuk VV; Titov VN
    Ter Arkh; 1997; 69(12):30-3. PubMed ID: 9503530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
    Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arteriosclerosis and blood lipids].
    Kipschidse NN; Schawgulidse NA
    Z Gesamte Inn Med; 1989 Mar; 44(6):175-6. PubMed ID: 2728559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.